<?xml version="1.0" encoding="UTF-8" ?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/"><channel><title>Uveitis</title><link>http://eyes.blog57.com/category/uveitis</link><description>Uveitis</description><language>en-us</language><lastBuildDate>Thu, 20 Nov 2008 13:57:19 GMT</lastBuildDate><item><title>Leptospirosis Getting an Early Start this Year</title><link>http://eyes.blog57.com/posts/1172128</link><guid isPermaLink="true">http://eyes.blog57.com/posts/1172128</guid><pubDate>Fri, 05 Jan 2007 14:55:50 GMT</pubDate><description>Leptospirosis Getting an Early Start this Year</description></item><item><title>EyeGate Pharma Secures $10M in Series B Venture Funding</title><link>http://eyes.blog57.com/posts/1159186</link><guid isPermaLink="true">http://eyes.blog57.com/posts/1159186</guid><pubDate>Fri, 10 Nov 2006 13:01:46 GMT</pubDate><description>EyeGate Pharma Secures $10M in Series B Venture Funding</description></item><item><title>EyeGate Pharma Starts U.S. Operations in Waltham, MA</title><link>http://eyes.blog57.com/posts/1158201</link><guid isPermaLink="true">http://eyes.blog57.com/posts/1158201</guid><pubDate>Thu, 09 Nov 2006 07:04:20 GMT</pubDate><description>EyeGate Pharma Starts U.S. Operations in Waltham, MA</description></item><item><title>Circadian IOP-Lowering Efficacy of Travoprost 0.004% Ophthalmic Solution Compared to Latanoprost 0.005%*</title><link>http://eyes.blog57.com/posts/1146272</link><guid isPermaLink="true">http://eyes.blog57.com/posts/1146272</guid><pubDate>Thu, 26 Oct 2006 02:54:00 GMT</pubDate><description>Circadian IOP-Lowering Efficacy of Travoprost 0.004% Ophthalmic Solution Compared to Latanoprost 0.005%*</description></item><item><title>Lux Biosciences Establishes European-Based Operations</title><link>http://eyes.blog57.com/posts/1126528</link><guid isPermaLink="true">http://eyes.blog57.com/posts/1126528</guid><pubDate>Thu, 05 Oct 2006 22:54:11 GMT</pubDate><description>Lux Biosciences Establishes European-Based Operations</description></item><item><title>pSivida Appoints Non-Executive Director to Audit Committee</title><link>http://eyes.blog57.com/posts/1123975</link><guid isPermaLink="true">http://eyes.blog57.com/posts/1123975</guid><pubDate>Tue, 03 Oct 2006 12:54:17 GMT</pubDate><description>pSivida Appoints Non-Executive Director to Audit Committee</description></item><item><title>Vishwa Samvada Kendra:</title><link>http://eyes.blog57.com/posts/1119825</link><guid isPermaLink="true">http://eyes.blog57.com/posts/1119825</guid><pubDate>Fri, 29 Sep 2006 06:54:23 GMT</pubDate><description>Vishwa Samvada Kendra:</description></item><item><title>A Novel, Preservative-Free Steroid Formulation for Use as an Anti-Inflammatory</title><link>http://eyes.blog57.com/posts/1113012</link><guid isPermaLink="true">http://eyes.blog57.com/posts/1113012</guid><pubDate>Fri, 22 Sep 2006 02:54:46 GMT</pubDate><description>A Novel, Preservative-Free Steroid Formulation for Use as an Anti-Inflammatory</description></item><item><title>TOO OLD T O O S O O N Research   and in the case of a Redwood City girl, inspiration and a lot of loving care   raise</title><link>http://eyes.blog57.com/posts/1104143</link><guid isPermaLink="true">http://eyes.blog57.com/posts/1104143</guid><pubDate>Fri, 15 Sep 2006 06:56:27 GMT</pubDate><description>TOO OLD T O O S O O N Research   and in the case of a Redwood City girl, inspiration and a lot of loving care   raise</description></item><item><title>FDA Expands Remicade® (Infliximab) Psoriatic Arthritis Indication ...</title><link>http://eyes.blog57.com/posts/1088034</link><guid isPermaLink="true">http://eyes.blog57.com/posts/1088034</guid><pubDate>Sat, 09 Sep 2006 04:59:53 GMT</pubDate><description>FDA Expands Remicade® (Infliximab) Psoriatic Arthritis Indication ...</description></item><item><title>Potentia Pharmaceuticals Licenses Complement Inhibitor from the ...</title><link>http://eyes.blog57.com/posts/1061374</link><guid isPermaLink="true">http://eyes.blog57.com/posts/1061374</guid><pubDate>Thu, 31 Aug 2006 04:53:38 GMT</pubDate><description>Potentia Pharmaceuticals Licenses Complement Inhibitor from the ...</description></item><item><title>Enzo Biochem Reports Long Term Retention of Antisense RNA in Phase I Study of HIV-1 Infected Subjects; Updated Report</title><link>http://eyes.blog57.com/posts/1058500</link><guid isPermaLink="true">http://eyes.blog57.com/posts/1058500</guid><pubDate>Wed, 30 Aug 2006 10:55:03 GMT</pubDate><description>Enzo Biochem Reports Long Term Retention of Antisense RNA in Phase I Study of HIV-1 Infected Subjects; Updated Report</description></item><item><title>Enzo Named Senior Party in US Patent &amp; Trademark Office Proceeding ...</title><link>http://eyes.blog57.com/posts/1035300</link><guid isPermaLink="true">http://eyes.blog57.com/posts/1035300</guid><pubDate>Thu, 24 Aug 2006 12:53:33 GMT</pubDate><description>Enzo Named Senior Party in US Patent &amp; Trademark Office Proceeding ...</description></item><item><title>Veterinarians See More Cases of Leptospirosis in Warm, Wet Weather</title><link>http://eyes.blog57.com/posts/1032354</link><guid isPermaLink="true">http://eyes.blog57.com/posts/1032354</guid><pubDate>Wed, 23 Aug 2006 19:00:49 GMT</pubDate><description>Veterinarians See More Cases of Leptospirosis in Warm, Wet Weather</description></item><item><title>Enzo Biochem Reports Long Term Retention of Antisense RNA in Phase ...</title><link>http://eyes.blog57.com/posts/1009801</link><guid isPermaLink="true">http://eyes.blog57.com/posts/1009801</guid><pubDate>Thu, 17 Aug 2006 20:53:55 GMT</pubDate><description>Enzo Biochem Reports Long Term Retention of Antisense RNA in Phase ...</description></item><item><title>Potentia Pharmaceuticals Licenses Complement Inhibitor from the University of Pennsylvania</title><link>http://eyes.blog57.com/posts/1005183</link><guid isPermaLink="true">http://eyes.blog57.com/posts/1005183</guid><pubDate>Wed, 16 Aug 2006 14:54:56 GMT</pubDate><description>Potentia Pharmaceuticals Licenses Complement Inhibitor from the University of Pennsylvania</description></item><item><title>Enzo Biochem Reports Court Ruling</title><link>http://eyes.blog57.com/posts/984647</link><guid isPermaLink="true">http://eyes.blog57.com/posts/984647</guid><pubDate>Fri, 11 Aug 2006 04:58:34 GMT</pubDate><description>Enzo Biochem Reports Court Ruling</description></item><item><title>Hasely Joaquim Crawford: a man possessed</title><link>http://eyes.blog57.com/posts/979545</link><guid isPermaLink="true">http://eyes.blog57.com/posts/979545</guid><pubDate>Wed, 09 Aug 2006 22:55:44 GMT</pubDate><description>Hasely Joaquim Crawford: a man possessed</description></item><item><title>All smiles despite pain</title><link>http://eyes.blog57.com/posts/957451</link><guid isPermaLink="true">http://eyes.blog57.com/posts/957451</guid><pubDate>Fri, 04 Aug 2006 08:54:55 GMT</pubDate><description>All smiles despite pain</description></item><item><title>Down in the catacombs with Hasely Crawford</title><link>http://eyes.blog57.com/posts/952025</link><guid isPermaLink="true">http://eyes.blog57.com/posts/952025</guid><pubDate>Wed, 02 Aug 2006 22:53:22 GMT</pubDate><description>Down in the catacombs with Hasely Crawford</description></item><item><title>New Study Shows Ankylosing Spondylitis Patients With Additional ...</title><link>http://eyes.blog57.com/posts/931515</link><guid isPermaLink="true">http://eyes.blog57.com/posts/931515</guid><pubDate>Fri, 28 Jul 2006 16:53:24 GMT</pubDate><description>New Study Shows Ankylosing Spondylitis Patients With Additional ...</description></item><item><title>A 47-Year-Old Man With Sudden Onset of Blindness, Pleocytosis, and Temporary Hearing Loss</title><link>http://eyes.blog57.com/posts/925573</link><guid isPermaLink="true">http://eyes.blog57.com/posts/925573</guid><pubDate>Thu, 27 Jul 2006 06:56:51 GMT</pubDate><description>A 47-Year-Old Man With Sudden Onset of Blindness, Pleocytosis, and Temporary Hearing Loss</description></item><item><title>European Rheumatologists Agree More Should Be Done to Identify and ...</title><link>http://eyes.blog57.com/posts/904137</link><guid isPermaLink="true">http://eyes.blog57.com/posts/904137</guid><pubDate>Fri, 21 Jul 2006 16:53:25 GMT</pubDate><description>European Rheumatologists Agree More Should Be Done to Identify and ...</description></item><item><title>pSivida to Present at The Sachs Associates: London Biotech Investment Forum</title><link>http://eyes.blog57.com/posts/899892</link><guid isPermaLink="true">http://eyes.blog57.com/posts/899892</guid><pubDate>Thu, 20 Jul 2006 14:54:32 GMT</pubDate><description>pSivida to Present at The Sachs Associates: London Biotech Investment Forum</description></item><item><title>Toxicara victim urges council to crackdown on irresponsible dog ...</title><link>http://eyes.blog57.com/posts/877662</link><guid isPermaLink="true">http://eyes.blog57.com/posts/877662</guid><pubDate>Sat, 15 Jul 2006 00:58:34 GMT</pubDate><description>Toxicara victim urges council to crackdown on irresponsible dog ...</description></item><item><title>pSivida's BioSilicon(TM) Demonstrates Adjuvant Properties ...</title><link>http://eyes.blog57.com/posts/850765</link><guid isPermaLink="true">http://eyes.blog57.com/posts/850765</guid><pubDate>Sat, 08 Jul 2006 08:52:59 GMT</pubDate><description>pSivida's BioSilicon(TM) Demonstrates Adjuvant Properties ...</description></item><item><title>pSivida to Present at the Wall Street Analyst Forum</title><link>http://eyes.blog57.com/posts/847038</link><guid isPermaLink="true">http://eyes.blog57.com/posts/847038</guid><pubDate>Fri, 07 Jul 2006 10:58:45 GMT</pubDate><description>pSivida to Present at the Wall Street Analyst Forum</description></item><item><title>Medidur(TM) Diabetic Macular Edema Programme: Government Approvals ...</title><link>http://eyes.blog57.com/posts/823990</link><guid isPermaLink="true">http://eyes.blog57.com/posts/823990</guid><pubDate>Sat, 01 Jul 2006 16:53:15 GMT</pubDate><description>Medidur(TM) Diabetic Macular Edema Programme: Government Approvals ...</description></item></channel></rss>